Novartis study shows skin cancer combo also works on lungs

June 6 (Reuters) - A Novartis trial of two drugs

against an aggressive lung cancer bodes well for broadening

their use beyond melanoma, the Swiss drugmaker told the American

Society of Clinical...

Read more